About PHARNEXT
Sector
Industry
Headquarters
Paris
Founded
2007
ISIN
FR001400N1P4
FIGI
BBG00D6ZW6S8
Pharnext SA develops and manufactures drugs for neurological diseases. Its products include R&D Pipeline, PXT3003, and PXT864 are used for the treatment of Charcot-Marie-Tooth disease, diabetic, and toxic peripheral neuropathies, as well as severe neurodegenerative diseases in general and peripheral neuropathies. The company was founded in 2007 by Daniel Cohen, Loic Heidsieck, Serguei Nabirotchkine, Oxana Guerassimenko and Ilya Chumakov and is headquartered in Paris, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALPHA is 0.0002 EUR — it has increased by 100.00% in the past 24 hours. Watch PHARNEXT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange PHARNEXT stocks are traded under the ticker ALPHA.
ALPHA reached its all-time high on Feb 21, 2019 with the price of 73,000,002,500,000,020.0000 EUR, and its all-time low was 0.0001 EUR and was reached on Jul 31, 2024. View more price dynamics on ALPHA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALPHA stock is 100.00% volatile and has beta coefficient of 0.95. Track PHARNEXT stock price on the chart and check out the list of the most volatile stocks — is PHARNEXT there?
Yes, you can track PHARNEXT financials in yearly and quarterly reports right on TradingView.
No, ALPHA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALPHA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARNEXT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARNEXT technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARNEXT stock shows the sell signal. See more of PHARNEXT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.